|
TMEM123 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.997600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.209600E-02 |
| Normal-vs-Stage2 |
5.303800E-01 |
| Normal-vs-Stage3 |
1.001830E-01 |
| Normal-vs-Stage4 |
2.044400E-01 |
| Stage1-vs-Stage2 |
5.717000E-01 |
| Stage1-vs-Stage3 |
7.767200E-01 |
| Stage1-vs-Stage4 |
9.341800E-01 |
| Stage2-vs-Stage3 |
4.462000E-01 |
| Stage2-vs-Stage4 |
6.019400E-01 |
| Stage3-vs-Stage4 |
9.104200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.759900E-02 |
| Normal-vs-AfricanAmerican |
6.997800E-01 |
| Normal-vs-Asian |
2.433600E-01 |
| Caucasian-vs-AfricanAmerican |
8.960300E-02 |
| Caucasian-vs-Asian |
8.777200E-01 |
| AfricanAmerican-vs-Asian |
4.787400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.469600E-02 |
| Normal-vs-Female |
7.138600E-01 |
| Male-vs-Female |
5.775800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.177190E-01 |
| Normal-vs-Extreme_Weight |
2.818200E-02 |
| Normal-vs-Obese |
3.927800E-01 |
| Normal-vs-Extreme_Obese |
1.778360E-03 |
| Normal_Weight-vs-Extreme_Weight |
5.900200E-01 |
| Normal_Weight-vs-Obese |
4.603800E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.290990E-01 |
| Extreme_Weight-vs-Obese |
1.311830E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.660590E-01 |
| Obese-vs-Extreme_Obese |
4.136100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.071400E-01 |
| Normal-vs-Age(41-60Yrs) |
5.117200E-01 |
| Normal-vs-Age(61-80Yrs) |
6.223100E-03 |
| Normal-vs-Age(81-100Yrs) |
9.282700E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.889010E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.247870E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.732050E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.195700E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.383600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.385800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.238420E-01 |
| Normal-VS-Type2 PRCC |
1.352170E-04 |
| Normal-VS-KIRP CIMP |
2.455700E-02 |
| Normal-VS-Unclassified PRCC |
9.249000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.776350E-03 |
| Type1 PRCC-VS-KIRP CIMP |
1.720430E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
2.962000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.42529999997065E-06 |
| Type2 PRCC-VS-Unclassified PRCC |
9.816300E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
1.160570E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.522400E-03 |
| Normal-vs-N1 |
3.382200E-01 |
| Normal-vs-N2 |
8.157000E-01 |
| N0-vs-N1 |
9.669900E-02 |
| N0-vs-N2 |
2.565600E-01 |
| N1-vs-N2 |
8.092200E-01 |
|
|
